Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Alfa-2b”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Active Not RecruitingNCT06468033
What this trial is testing

P1101 in Treating Patients With Early PMF or Overt PMF at Low or Intermediate-1 Risk

Who this might be right for
Primary MyelofibrosisMyeloproliferative Neoplasm
PharmaEssentia 160
Post-approval studies (Phase 4)Study completedNCT00277862
What this trial is testing

Pegylated Interferon and Ribavirin Therapy in Chronic Hepatitis Genotype 4

Who this might be right for
Hepatitis C
Ain Shams University 280
Post-approval studies (Phase 4)Study completedNCT00087646
What this trial is testing

REPEAT Study - A Study of PEGASYS (Peginterferon Alfa-2a (40KD)) Therapy in Combination With COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Who Did Not Respond to Previous PegIntron (Peginterferon Alfa-2b (12KD))/Ribavirin Combination Therapy

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 948
Testing effectiveness (Phase 2)Study completedNCT02089685
What this trial is testing

Safety and Tolerability of Pembrolizumab (MK-3475) + Pegylated Interferon Alfa-2b and Pembrolizumab+ Ipilimumab in Participants With Advanced Melanoma or Renal Cell Carcinoma (MK-3475-029/KEYNOTE-29)

Who this might be right for
Renal Cell CarcinomaMelanoma
Merck Sharp & Dohme LLC 295
Not applicableWithdrawnNCT01062659
What this trial is testing

Cellular Immune Responses in the Liver in Chronic Hepatitis C (CHC) Patients

Who this might be right for
Hepatitis C, ChronicLiver DiseasesVirus Diseases
University of Ulm
Post-approval studies (Phase 4)UnknownNCT00117533
What this trial is testing

Pegylated Interferon Alfa-2b Plus Ribavirin in Chronic Hepatitis B and Delta

Who this might be right for
Chronic Hepatitis BChronic Hepatitis D
National Taiwan University Hospital 20
Early research (Phase 1)Study completedNCT01943422
What this trial is testing

Safety and Efficacy Study of Vemurafenib and High-dose Interferon Alfa-2b in Melanoma

Who this might be right for
Melanoma
John Kirkwood 7
Post-approval studies (Phase 4)Not Yet RecruitingNCT07231276
What this trial is testing

Prospective Cohort Study on PEG-IFN-α-2b in Improving Clinical Cure Rate of Pediatric Patients With Chronic Hepatitis B

Who this might be right for
HBVChronic Hepatitis B Virus
Nanfang Hospital, Southern Medical University 113
Testing effectiveness (Phase 2)Study completedNCT00005012
What this trial is testing

Safety and Effectiveness of PEG-Intron in HIV-Infected Patients

Who this might be right for
HIV Infections
Schering-Plough 250
Testing effectiveness (Phase 2)Ended earlyNCT01701063
What this trial is testing

An Open-Label Study of the Effect of Telaprevir in Combination With Peginterferon Alfa-2b and Ribavirin in Pediatric Subjects Infected With Hepatitis C Virus

Who this might be right for
Hepatitis C
Vertex Pharmaceuticals Incorporated 42
Large-scale testing (Phase 3)Study completedNCT00134030
What this trial is testing

Combination Chemotherapy, PEG-Interferon Alfa-2b, and Surgery in Treating Patients With Osteosarcoma

Who this might be right for
Localized OsteosarcomaMetastatic Osteosarcoma
Children's Oncology Group 1,334
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07646821
What this trial is testing

A Phase 1b/2 Study of Ropeginterferon Alfa-2b Added to Azacitidine in Newly Diagnosed MDS/AML (≥ 10% Blasts) With TP53 Mutations

Who this might be right for
RopeginterferonAlfa-2bAzacitidine+1 more
M.D. Anderson Cancer Center 30
Large-scale testing (Phase 3)Study completedNCT00230958
What this trial is testing

Study of Viramidine to Ribavirin in Patients With Chronic Hepatitis C Who Are Treatment-Naive

Who this might be right for
Chronic Hepatitis C
Bausch Health Americas, Inc. 900
Large-scale testing (Phase 3)Study completedNCT02523638
What this trial is testing

Study to Assess the Self-administration of AOP2014 Using a Pen, Developed for the Treatment of Polycythemia Vera Patients

Who this might be right for
Polycythemia Vera
AOP Orphan Pharmaceuticals AG 30
Large-scale testing (Phase 3)Ended earlyNCT03552549
What this trial is testing

SCH 54031 PEG12000 Interferon Alfa-2b (PEG Intron, MK-4031) vs. INTRON®A (SCH 30500, MK-2958) as Adjuvant Therapy for Melanoma (C98-135, MK-4031-002)

Who this might be right for
Melanoma
Merck Sharp & Dohme LLC 126
Testing effectiveness (Phase 2)Ended earlyNCT00305383
What this trial is testing

Viral Kinetic Study With Viramidine in Therapy-Naive Patients With Chronic Hepatitis C

Who this might be right for
Hepatitis C, Chronic
Bausch Health Americas, Inc. 100
Not applicableStudy completedNCT01460875
What this trial is testing

Recombinant Interferon Alfa-2b in Treating Patients With Melanoma

Who this might be right for
Stage IA Skin MelanomaStage IB Skin MelanomaStage IIA Skin Melanoma+6 more
William Carson 34
Large-scale testing (Phase 3)Ended earlyNCT00122629
What this trial is testing

Triple Therapy With Peg-Interferon Alfa-2b/Ribavirin Plus Amantadine Compared to Standard Peg-Interferon Alfa-2b/Ribavirin for Previous Hepatitis C Virus (HCV) Non Responders

Who this might be right for
Hepatitis C, Chronic
French National Agency for Research on AIDS and Viral Hepatitis 405
Large-scale testing (Phase 3)Study completedNCT01425203
What this trial is testing

The Effect of Boceprevir in Russian Participants Diagnosed With Chronic Hepatitis C Genotype 1 (P08160)

Who this might be right for
Chronic Hepatitis C Genotype 1
Merck Sharp & Dohme LLC 238
Large-scale testing (Phase 3)Study completedNCT00221702
What this trial is testing

PegIntron Versus IntronA in CMAJCC Stage II (EADO 2001/CMII Trial)

Who this might be right for
MelanomaNeoplasm Metastasis
University Hospital, Bordeaux 898
Next Page